|
Combined effect of alcohol and category of benign breast disease histology on breast cancer riska |
|||||||
| Jointly-classifiedb |
Stratifiedc> |
||||||
|
|
|||||||
| Category of BBD |
Recent alcohol consumption (g/day) |
Cases |
Controls |
OR (95% CI)d |
OR (95% CI)e |
OR (95% CI)d |
OR (95% CI)e |
|
|
|||||||
| Nonproliferative |
|||||||
| 0 |
21 |
178 |
1.00 (Ref) |
1.00 (Ref) |
1.00 (Ref) |
1.00 (Ref) |
|
| <5 |
27 |
165 |
1.41 (0.76–2.60) |
1.42 (0.77–2.65) |
1.34 (0.72–2.50) |
1.46 (0.75–2.85) |
|
| 5–15 |
14 |
95 |
1.27 (0.62–2.62) |
1.25 (0.60–2.60) |
1.31 (0.63–2.74) |
1.15 (0.53–2.53) |
|
| ≥ 15 |
7 |
36 |
1.67 (0.66–4.27) |
1.67 (0.65–4.34) |
1.85 (0.71–4.84) |
1.90 (0.67–5.39) |
|
| P for trendf |
0.13 |
0.20 |
|||||
| Proliferative without atypia |
|||||||
| 0 |
46 |
205 |
2.04 (1.17–3.57) |
1.99 (1.13–3.50) |
1.00 (Ref) |
1.00 (Ref) |
|
| <5 |
52 |
235 |
1.91 (1.11–3.29) |
1.82 (1.05–3.16) |
0.99 (0.63–1.55) |
0.99 (0.62–1.56) |
|
| 5–15 |
34 |
123 |
2.43 (1.34–4.41) |
2.40 (1.31–4.39) |
1.17 (0.70–1.94) |
1.14 (0.67–1.91) |
|
| ≥ 15 |
8 |
60 |
1.15 (0.48–2.75) |
1.09 (0.45–2.62) |
0.59 (0.26–1.33) |
0.61 (0.26–1.41) |
|
| P for trendf |
0.49 |
0.58 |
|||||
| Proliferative with atypia |
|||||||
| 0 |
23 |
40 |
5.57 (2.77–11.21) |
5.58 (2.74–11.38) |
1.00 (Ref) |
1.00 (Ref) |
|
| <5 |
30 |
45 |
6.65 (3.43–12.90) |
6.48 (3.31–12.70) |
1.28 (0.62–2.67) |
1.29 (0.60–2.78) |
|
| 5–15 |
14 |
25 |
5.35 (2.39–12.01) |
5.26 (2.30–12.04) |
1.03 (0.42–2.51) |
1.02 (0.39–2.68) |
|
| ≥ 15 |
6 |
16 |
3.65 (1.27–10.47) |
3.46 (1.19–10.09) |
0.66 (0.22–1.97) |
0.59 (0.19–1.89) |
|
| P for trendf |
0.21 |
0.17 |
|||||
|
aNurses' Health Study I (1976 to 1994) and II (1989 to 1995). b Joint classification of BBD category and alcohol consumption where the reference group is women with nonproliferative BBD and 0 alcohol consumption. c The analysis is stratified by type of BBD where the reference group is women with 0 alcohol consumption within each category of BBD. dAdjusted for age at diagnosis, year of biopsy, and follow-up interval. eAdjusted for age at diagnosis, year of biopsy, and follow-up interval, age at menarche, body mass index quartiles, family history of breast cancer, parity/age at first birth, menopausal status/type of menopause, duration of postmenopausal hormone use. fTest for trend based on Wald test for continuous alcohol consumption. BBD, benign breast disease; CI, confidence interval; OR, odds ratio; Ref, reference group for statistical comparisons. | |||||||
Tamimi et al. Breast Cancer Research 2005 7:R555 doi:10.1186/bcr1039 |
|||||||